Click here to be put on Neostem, Inc.'s email distribution list
NeoStem, Inc., headquartered in New York City, operates three key business segments: 1) adult stem cells in the U.S.; 2) adult stem cells in China; 3) generic pharmaceuticals in China. The Company has expertise in stem cell collection, adult stem cell banking and a portfolio of stem cell therapeutic applications that will allow it to generate revenues in the stem cell business near term. NeoStem acquired a 51% stake in Suzhou Erye Pharmaceuticals, Ltd. (“Erye”) through its acquisition of China Biopharmaceuticals in October 2009. Erye is a vertically-integrated manufacturer and distributor of generic antibiotics in China. NeoStem will leverage the pharmaceutical platform to help accelerate its stem cell therapy development.